A 2 mg vial of Egrifta SV is reconstituted with exactly 0.5 mL of sterile water
In the SURMOUNT-1 trial, people treated with tirzepatide lost up to 22.5% of their body weight over 72 weeks , making it even more effective than semaglutide (NEJM tirzepatide study)
ProHealth BPC-157 is a dietary supplement, not an FDA-approved drug
What Happened The suppliers commercial invoice described the shipment only as laboratory chemicals. Because the description lacked sufficient detail, customs authorities requested additional documentation before continuing the clearance process
Academic institutions, independent research organizations, or collaborative pharmaceutical initiatives could theoretically pursue these questions, though competitive dynamics make such studies unlikely in the near term
Presented for research literature review only Ong LK et al